AK
Avinash Kumar
About Avinash Kumar
Data last updated:
Avinash Kumar is a Director at Emuric Pharmaceuticals Private Limited (since 2016). The companies operate in Healthcare and Food And Beverages. Emuric Pharmaceuticals Private Limited reported revenue of ₹18.9 Lakh (FY 2025). Earlier, Avinash Kumar was a Director at Sarfans Vegan Food Products Private Limited (2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 13 Jun 2016 | 2016 | ₹18.9 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 03 Mar 2021 | 2021 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Avinash Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rahul Kumar | 07542241 | Emuric Pharmaceuticals Private Limited | Director |
| Ravi Ranjan Singh | 07542242 | Emuric Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Avinash Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Avinash Kumar
Avinash Kumar currently holds 1 directorship: Emuric Pharmaceuticals Private Limited (Director, since 13 Jun 2016, revenue ₹18.9 Lakh (FY 2025)).
Avinash Kumar was first appointed on 13 Jun 2016 as Director at Emuric Pharmaceuticals Private Limited. The most recent appointment on record is 03 Mar 2021 at Sarfans Vegan Food Products Private Limited.
Avinash Kumar held 1 earlier board appointment: Sarfans Vegan Food Products Private Limited (Director, 03 Mar 2021 to 09 Aug 2021).
The current boards of Avinash Kumar's companies include Rahul Kumar (Emuric Pharmaceuticals Private Limited), Ravi Ranjan Singh (Emuric Pharmaceuticals Private Limited).